Author: Barnaby Page

Video presentation: disharmony and the EU TPD

Written by Barnaby Page || 30th June 2016 || Regulatory briefing |

At June’s Global Forum on Nicotine in Warsaw, ECigIntelligence editorial director Barnaby Page took a look at some of the inconsistencies that are emerging in European regulation of e-cigarettes despite the standardisation imposed by the EU Tobacco Products Directive...

U.S. vape stores: how the top five chains compare

Written by Barnaby Page || 28th June 2016 || Market reports |

Our analysis of the top five vape store chains in the U.S. reveals distinct patterns in geographical distribution, and offers some insight into how these chains are evolving against the background of a maturing...

Sharp increase in Canadian vaper numbers and sales

Written by Barnaby Page || 27th June 2016 || Market reports |

In this report we look at Canada, a market-oriented, high-tech industrial society in the trillion-dollar class with high living standards. There are no federal laws related to e-cigarettes – despite calls to clarify a confused situation – so...

Opinion: how big is the risk of diacetyl litigation?

Written by Barnaby Page || 26th May 2016 || Business briefing |

Plaintiffs’ attorneys in the U.S. are always on the hunt for a new target to sue. And, having had some success suing diacetyl manufacturers over workers’ exposure to the chemical in microwave popcorn plants, attorneys are now beginning...

Right on deadline, Ireland transposes the TPD

Written by Barnaby Page || 20th May 2016 || Regulatory briefing |

The Republic of Ireland has succeeded in transposing the EU’s Tobacco Products Directive (TPD) at the eleventh hour, with recently-appointed health minister Simon Harris signing the necessary regulations to come into force...

PMTAs can use many kinds of scientific support, FDA says

Written by Barnaby Page || 10th May 2016 || Regulatory briefing |

The U.S. Food and Drug Administration (FDA) believes most e-cigarette manufacturers will need to conduct fresh scientific research in order to obtain authorisation for their products under the newly-published deeming regulations – but not necessarily full-blown clinical...